* Alder Biopharmaceuticals, Inc. announces commencement of public offering of common stock

* Alder Biopharmaceuticals Inc - Intends to offer and sell, 12.5 million shares of its common stock in an underwritten public offering

* Alder Biopharmaceuticals - Intends to use net proceeds from offering, to fund continued development of eptinezumab, among the others Source text for Eikon: Further company coverage: